Bai Hua She She Cao (Oldenlandia or Heydyotis)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Bai Hua She She Cao?

  Our record gives 15–60 g, using the entire plant. That is a wide range, and a high ceiling by materia medica standards — the herb is bland-tasting, low in acute toxicity, and traditionally used at large doses when treating toxic sores, intestinal abscess or masses; smaller doses sit at the lower end when it is one supporting herb among many.

  • Decoction — 15–60 g of the whole dried plant.
  • Part used — the entire plant (aerial parts with root), harvested in summer or autumn and dried.
  • Fresh herb — traditionally used fresh, crushed, as an external application for toxic sores and snakebite; no internal dose applies.

  Source: our own herb record dosage and part-used entries, cross-referenced against multiple online sources. Reference only — not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions for Bai Hua She She Cao?

  Our record's stated contraindication is pregnancy. Beyond that, the herb is bitter and cold, so the general cautions for cold, heat-clearing herbs apply: it is not suited to patients with cold from deficiency, weak digestion or chronic loose stools, and it is not a long-term tonic.

  • Pregnancy — contraindicated per our record.
  • Spleen and Stomach deficiency-cold — poor appetite, loose stools, cold aversion; cold, bitter herbs at the doses used here can worsen digestion.
  • Product identity — because demand for this herb is high, look-alike species are documented in the market (see toxicity). Correctly identified material matters.
  • Cancer care — this herb appears constantly in online material about cancer. The research below is overwhelmingly laboratory and animal work. It is not a cancer treatment, and anyone under oncological care should raise any herb with their treating team before use, not instead of it.

  Source: our own herb record caution; general category cautions cross-referenced against multiple online sources; authentication literature cited under toxicity. Reference information, not medical advice.

Chinese Herb Toxicity & Overdose

• Is Bai Hua She She Cao toxic?

  The herb is not classed as toxic and is used at large doses (up to 60 g) in traditional practice. It is a common ingredient in southern Chinese cooling herbal teas, which reflects a long history of everyday use. The practical risk is not intrinsic toxicity but substitution: two look-alike species are commonly encountered in the market.

  • Documented market adulterants — Hedyotis corymbosa (colloquially Shui Xian Cao) and Hedyotis brachypoda (colloquially Ni Ding Jing Cao) are close morphological look-alikes and are commonly encountered as substitutes; researchers have sequenced the complete chloroplast genomes of all three and proposed DNA barcoding markers to tell them apart.
  • Chemical discrimination — metabolomic profiling has identified marker compounds that distinguish H. diffusa from H. corymbosa, and a chemical marker has been proposed specifically for the quality control of Scleromitrion diffusum.
  • Practical implication — a batch that is not genuine is not necessarily dangerous, but it is not the medicine described here. Provenance and testing matter for this herb more than most.

  Sources: PMID 33467716, PMC 7829813 (chloroplast genome sequencing and DNA barcoding of H. diffusa and its common adulterants); PMID 29941819, PMC 6100407 (UPLC-QTOF/MS discrimination of H. diffusa and H. corymbosa); PMC 12069056, DOI 10.3389/fchem.2025.1600769 (proposed quality-control marker for Scleromitrion diffusum). Neutral reference facts, not a safety guarantee.

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Bai Hua She She Cao (Hedyotis diffusa)?

  Yes — a very large body of it, and it is almost entirely preclinical. Hundreds of laboratory papers report antitumour effects of this herb in cancer cell lines and in tumour-bearing mice. What is missing is the next step: well-designed randomised controlled trials of the herb in patients. A search of the clinical-trial literature for the single herb returns only a handful of decades-old trials of multi-herb formulas in which it was one ingredient. No clinical benefit in humans has been demonstrated, and nothing here should be read as a cancer treatment.

  • Scope of the preclinical evidence — a 2026 scoping review following PRISMA-ScR guidance mapped 59 preclinical studies published 2016–2025 across in vitro and in vivo models and multiple cancer types. Reported effects included suppression of proliferation, induction of apoptosis and ferroptosis, inhibition of epithelial–mesenchymal transition and angiogenesis, and enhanced cytotoxic lymphocyte activity. An accompanying network-pharmacology analysis identified 94 immune- and tumour-microenvironment-related targets converging on PI3K–Akt, STAT3, EGFR and SRC signalling. Every one of these findings is from cells or animals.
  • The herb pair — much of the literature studies Hedyotis diffusa together with Scutellaria barbata (Ban Zhi Lian) rather than alone, mirroring how it is actually prescribed. Reviews of this pair in hepatocellular carcinoma models exist, again preclinical.
  • Chemistry — the characteristic constituents are iridoid glycosides, anthraquinones, flavonoids, coumarins, phenolic acids and triterpenes; a chromosome-level genome assembly has been used to map the iridoid biosynthetic pathway.
  • Other preclinical directions — liver fibrosis models, colitis-associated colorectal cancer models, and antiviral screening. All laboratory-stage.
  • Quality of the literature — worth noting that at least one study in this field has been retracted, and a large share of the output is network-pharmacology and molecular-docking modelling rather than experimental work. Volume of publication is not the same as strength of evidence.

  Honest summary: this is one of the most-researched herbs in the Chinese materia medica by paper count, and one of the least-proven by clinical standards. It is a legitimate subject of laboratory investigation and a traditional heat-clearing, toxin-resolving herb. It is not a demonstrated treatment for any disease.

  Sources: PMID 41749926, PMC 12939048, DOI 10.3390/cancers18040672 (scoping review of 59 preclinical studies plus network pharmacology); PMID 23600735, DOI 10.1080/10286020.2013.781589 (chemical and preclinical studies review); PMID 42261445, PMC 13242808 (review of the Hedyotis diffusa–Scutellaria barbata herb pair, preclinical); PMC 12222090, DOI 10.3389/fpls.2025.1607226 (chromosome-level genome and iridoid biosynthesis). Research context, not a therapeutic claim.

Chinese Herb Notes

• Is Bai Hua She She Cao the same as Bai Hua She, She Gan or She Chuang Zi?

  No — these are four completely different medicinals that share syllables in pinyin and nothing else. The syllable shé (蛇, “snake”) appears in several unrelated herb names, and it is one of the most common sources of confusion in the materia medica. Bai Hua She She Cao is a small flowering plant; it contains no animal material at all.

  • Bai Hua She She Cao (白花蛇舌草) — Herba Hedyotidis Diffusae, this herb. A plant. Bitter, sweet, cold; clears heat and toxins.
  • Bai Hua She (白花蛇) — Agkistrodon or Bungarus, an actual medicinal snake. A wind-damp dispelling animal medicinal, in an entirely different category. Dropping the final two syllables changes the substance completely.
  • She Gan (射干) — Rhizoma Belamcandae, belamcanda rhizome, used for phlegm-heat in the throat. Note the first syllable is shè (“to shoot”), not shé (“snake”) — a different character and a different word.
  • She Chuang Zi (蛇床子) — Fructus Cnidii, cnidium seed, a warm, drying, externally applied herb for damp itching and a Kidney-yang tonic. Warm where Bai Hua She She Cao is cold.
  • She Tui (蛇蜕) / Wu Shao She (乌梢蛇) — snake slough and Zaocys, both animal medicinals; again unrelated.

  Closest genuine relative in use: Ban Zhi Lian (Scutellaria barbata) is the herb Bai Hua She She Cao is most often paired with — the two are so routinely combined in modern Chinese prescribing that most of the modern laboratory literature studies them as a fixed herb pair. Other common companions are Ban Bian Lian for toxin and swelling, Bai Jiang Cao for intestinal abscess, and Yu Xing Cao for toxic heat. (Traditional formula context, not treatment advice.)

  What is Bai Hua She She Cao called botanically?

  Our record uses Herba Hedyotidis Diffusae — the plant Hedyotis diffusa Willd., also long known as Oldenlandia diffusa. Taxonomic revision within the Rubiaceae has moved the species to the genus Scleromitrion, so the current accepted name in much of the recent literature is Scleromitrion diffusum (Willd.) R.J.Wang. All three names refer to the same plant; papers published under any of them are about this herb.

  Source: our own herb records for each medicinal named above (Latin, category, nature and flavour), cross-referenced against multiple online sources; current botanical name usage per PMID 41896653 and PMC 12069056.